BioMerieux Total Liabilities 2017-2024 | BMXMF

BioMerieux total liabilities from 2017 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • BioMerieux total liabilities for the quarter ending December 31, 2024 were $1.687B, a 3.79% increase year-over-year.
  • BioMerieux total liabilities for 2024 were $1.687B, a 3.43% increase from 2023.
  • BioMerieux total liabilities for 2023 were $1.631B, a 0.29% increase from 2022.
  • BioMerieux total liabilities for 2022 were $1.626B, a 4.68% decline from 2021.
BioMerieux Annual Total Liabilities
(Millions of US $)
2024 $1,687
2023 $1,631
2022 $1,626
2021 $1,706
2020 $1,652
2019 $1,711
2018 $1,637
2017 $1,417
2016 $1,557
2015 $0
BioMerieux Quarterly Total Liabilities
(Millions of US $)
2024-12-31 $1,687
2023-12-31 $1,631
2023-06-30 $1,515
2022-12-31 $1,626
2022-06-30 $1,625
2021-12-31 $1,706
2021-06-30 $1,697
2020-12-31 $1,652
2019-12-31 $1,711
2019-06-30 $1,720
2018-12-31 $1,637
2018-06-30 $1,394
2017-12-31 $1,417
2017-06-30 $1,412
2016-12-31 $1,557
Sector Industry Market Cap Revenue
Medical Medical Services $16.861B $4.307B
bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.621B 26.94
CVS Health (CVS) United States $84.680B 10.52
Elevance Health (ELV) United States $78.955B 10.19
Cencora (COR) United States $57.765B 20.10
DiDi Global (DIDIY) China $23.297B 24.75
Natera (NTRA) United States $21.640B 0.00
Labcorp Holdings (LH) United States $21.549B 17.48
EUROFINS SCIENT (ERFSF) Luxembourg $13.690B 0.00
Solventum (SOLV) United States $12.990B 13.75
CochLear (CHEOY) Australia $12.847B 0.00
ICON (ICLR) Ireland $12.241B 11.38
Revvity (RVTY) United States $11.865B 20.42
Viatris (VTRS) United States $10.868B 3.73
Avantor (AVTR) United States $9.370B 13.61
Medpace Holdings (MEDP) United States $9.269B 24.62
HealthEquity (HQY) United States $8.917B 39.06
Sonic Healthcare (SKHHY) Australia $8.417B 0.00
Charles River Laboratories (CRL) United States $7.779B 15.24
Caris Life Sciences,�Inc (CAI) United States $6.688B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.952B 29.17
BrightSpring Health Services (BTSG) United States $3.769B 34.58
Sotera Health (SHC) United States $3.290B 18.69
Surgery Partners (SGRY) United States $2.853B 37.10
Alignment Healthcare (ALHC) United States $2.712B 0.00
Concentras Parent (CON) United States $2.615B 15.11
Organon (OGN) United States $2.587B 2.75
GeneDx Holdings (WGS) United States $2.432B 93.65
Progyny (PGNY) United States $2.080B 45.79
PACS (PACS) United States $1.972B 0.00
Ardent Health (ARDT) United States $1.970B 8.40
Premier (PINC) United States $1.805B 13.70
GoodRx Holdings (GDRX) United States $1.729B 34.57
Teladoc Health (TDOC) United States $1.493B 0.00
Establishment Labs Holdings (ESTA) $1.271B 0.00
Pediatrix Medical (MD) United States $1.159B 8.82
CareDx (CDNA) United States $1.072B 16.74
Agilon Health (AGL) United States $0.989B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
AMN Healthcare Services Inc (AMN) United States $0.846B 7.92
Nutex Health (NUTX) United States $0.766B 11.59
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.610B 4.11
InnovAge Holding (INNV) United States $0.574B 0.00
LifeMD (LFMD) United States $0.544B 0.00
SBC Medicals (SBC) United States $0.504B 0.00
Sonida Senior Living (SNDA) United States $0.468B 0.00
Auna S.A (AUNA) Luxembourg $0.465B 10.47
Omada Health (OMDA) $0.450B 0.00
So-Young (SY) China $0.423B 0.00
Enhabit (EHAB) United States $0.370B 30.42
Performant Healthcare (PHLT) United States $0.333B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.324B 0.00
Beauty Health (SKIN) United States $0.265B 0.00
Oncology Institute (TOI) United States $0.223B 0.00
DocGo (DCGO) United States $0.158B 25.83
Pheton Holdings (PTHL) China $0.128B 0.00
Sera Prognostics (SERA) United States $0.102B 0.00
KindlyMD (NAKA) United States $0.078B 0.00
IceCure Medical (ICCM) Israel $0.067B 0.00
Ascend Wellness Holdings (AAWH) United States $0.062B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
ModivCare (MODV) United States $0.055B 0.00
Biodesix (BDSX) United States $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
Basel Medical Group (BMGL) Singapore $0.034B 0.00
OSR Holdings (OSRH) United States $0.026B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00